EX-99.3 5 c54395exv99w3.htm EX-99.3 exv99w3
Exhibit 99.3
HiveLive, Inc.
(a development stage company)
Statements of Operations
(unaudited)
                 
    Six Months Ended
June 30,
 
    2009     2008  
 
               
Revenues
  $ 553,079     $ 195,525  
 
           
Operating expenses
               
Sales and marketing
    1,300,329       721,262  
Direct costs and expenses
    73,061       31,843  
Product development
    523,579       335,027  
General and administrative
    647,761       367,975  
 
           
Total operating expenses
    2,544,730       1,456,107  
 
           
 
               
Loss from operations
    (1,991,651 )     (1,260,582 )
 
           
 
               
Other income (expense)
               
Interest income
    12,827       140  
Interest expense
    (20,656 )     (410 )
 
           
Total other income
    (7,829 )     (270 )
 
           
 
               
Net loss
  $ (1,999,480 )   $ (1,260,852 )
 
           


 

HiveLive, Inc.
(a development stage company)
BALANCE SHEET
(unaudited)
         
    June 30  
    2009  
Assets
       
Current assets
       
Cash and cash equivalents
    1,201,287  
Restricted cash
    50,000  
Accounts receivable, net
    255,178  
Deferred direct costs of revenue
    139,193  
Other assets
    39,485  
 
     
Total current assets
    1,685,143  
 
       
Non-current assets
       
Property and equipment, net
    194,307  
Deferred direct costs of revenue, net of current portion
    76,943  
Deposits
    23,907  
 
     
Total non-current assets
    295,157  
 
     
 
       
Total assets
    1,980,300  
 
     
 
       
Liabilities & Stockholders’ Equity
       
 
       
Current liabilities
       
Accounts payable and accrued liabilities
    64,741  
Deferred revenue
    490,477  
Current portion of long-term debt
    989,093  
 
     
Total current liabilities
    1,544,311  
 
       
Non-current liabilities
       
Long-term debt, net of current portion
     
 
     
Total Liabilities
    1,544,311  
 
     
 
       
Stockholders’ equity
       
Preferred Series A stock, $0.001 par value. Authorized 13,392,034 and 20,528,948 shares; 13,241,920 shares issued and outstanding as of June 30, 2009 and 2008, respectively
    2,171,984  
Preferred Series B stock, $0.001 par value. Authorized 17,009,495 shares issued and outstanding as of June 30, 2009 and 2008 respectively
    5,526,617  
Common stock, $0.001 par value. Authorized 50,000,000 and 11,782,250 shares; 9,076,500 shares issued and outstanding at June 30, 2009 and 2008, respectively
    11,782  
Additional paid-in capital
    51,683  
Deficit accumulated during the development stage
    (7,326,077 )
 
     
Total stockholders’ equity
    435,989  
 
     
 
       
Total liabilities & stockholder’s equity
    1,980,300  
 
     


 

HiveLive, Inc.
(a development stage company)
Statements of Cash Flows
(unaudited)
                 
    Six Months Ended
June 30,
 
    2009     2008  
Cash flows from operating activities
               
Net loss
    (1,999,480 )     (1,260,852 )
Adjustments to reconcile net loss to net cash used in operating activities
               
Depreciation expense
    40,646       14,138  
Common stock issued for services
           
Stock-based compensation
           
Value of warrants issued upon debt conversion
           
Amortization of debt discount
           
Changes in operating assets and liabilities
               
Accounts receivable
    (129,770 )     (97,252 )
Prepaid commissions
    4,981        
Other assets
    18,190       (24,562 )
Deposits
          (6,977 )
Accounts payable and accrued liabilities
    (107,850 )     (20,834 )
Deferred revenue
    261,476       39,100  
 
           
Net cash used in operating activities
    (1,911,807 )     (1,357,239 )
 
               
Cash flows from investing activities
               
Purchase of property & equipment
    (14,031 )     (90,303 )
Restricted cash
           
 
           
Net cash used in investing activities
    (14,031 )     (90,303 )
 
               
Cash flows from financing activities
               
Proceeds from issuance of preferred stock
          5,615,724  
Equity offering costs
             
Proceeds from convertible note payable
           
Proceeds from the issuance of common stock
    10,890        
 
           
 
               
Net cash provided by financing activities
    10,890       5,615,724  
 
               
Net increase (decrease) in cash and cash equivalents
    (1,914,948 )     4,168,182  
Cash and cash equivalents — beginning of period
    3,116,235       491,454  
 
           
Cash and cash equivalents — end of period
    1,201,287       4,659,636